Key result
New study design outlines plans to evaluate COVID-19 pandemic impact on AMI admissions across India.
Why the study?
COVID-19 pandemic lockdowns had an unintentional impact on acute cardiovascular care, prompting an evaluation of its impact on acute myocardial infarction admission patterns across India.
Does the COVID-19 pandemic and lockdown reduce acute myocardial infarction admissions and alter care metrics in India?
Cross-Sectional
Yes
Does the COVID-19 pandemic and lockdown reduce acute myocardial infarction admissions and alter care metrics in India?
This study design outlines a multicenter effort to evaluate the impact of the COVID-19 pandemic on acute myocardial infarction admissions and care metrics in India.
Outlines multicenter study of pandemic effects on AMI admissions in India; leaves open whether presentations declined or care metrics changed.
BACKGROUND: COVID-19 pandemic has affected around 20million patients worldwide and 2.0 million cases from India. The lockdown was employed to delay the pandemic. However, it had an unintentional impact on acute cardiovascular care, especially acute myocardial infarction (AMI). Observational studies have shown a decrease in hospital admissions for AMI in several developed countries during the pandemic period. We aimed to evaluate the impact of COVID-19 on the AMI admissions patterns across India. METHODS: In this multicentric, retrospective, cross-sectional study, we included all AMI cases admitted to participating hospitals during the study period 15th March to 15th June 2020 and compared them using a historical control of all cases of AMI admitted during the corresponding period in the year 2019. Major objective of the study is to analyze the changes inthe number of hospital admissions for AMI in hospitals across India. In addition, we intend to evaluate the impact of COVID-19 on the weekly AMI admission rates, and other performance measures like rates of thrombolysis/primary percutaneous interventions (PCI), window period, door to balloon time, and door to needle time. Other objectives include evaluation of changes in the major complications and mortality rates of AMI and its predictors during COVID-19 pandemic. CONCLUSIONS: This CSI-AMI study will provide scientific evidence about the impact of COVID-19 on AMI care in India. Based on this study, we may be able to suggest appropriate changes to the existing MI guidelines and to educate the public regarding emergency care for AMI during COVID-19 pandemic.
No takes yet. Share an insight, caveat, or question.
Ramakrishnan et al. (2020) conducted a cross-sectional in Acute myocardial infarction (AMI). COVID-19 pandemic period vs. Historical control (corresponding period in 2019) was evaluated on Changes in the number of hospital admissions for AMI. This rationale and design paper outlines a multicentric, retrospective, cross-sectional study to evaluate the impact of the COVID-19 pandemic on acute myocardial infarction admissions across India.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: